Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials
Journal of Pharmacy and Pharmaceutical Sciences - Canada
doi 10.18433/j36c8n
Full Text
Open PDFAbstract
Available in full text
Date
April 11, 2017
Authors
Publisher
University of Alberta Libraries